End-to-end service from healthy donor identification through high-quality collections and source material or allogeneic therapy delivery.
Services Our Clients Request Most Often
Allogeneic Cell Sourcing
- Offer a stable supply of healthy, screened donors (repeat donations possible if donor is willing) with understanding of donor characteristics most critical to the end product
- Onboard and manage apheresis network specifically selected to collect for your therapy
- Make donor outreach, including screening and testing for donor eligibility and obtaining full consent
- Coordinate and schedule logistics with all stakeholders within the parameters you set up
Autologous Supply Chain Management
Unique autologous cell therapy supply chain management model optimized for your product to meet your timelines and reduce your risk.
- Support the full supply chain for every shipment of your autologous cell therapy
- Coordinate, schedule and communicate with all stakeholders from collection through therapy delivery
- Use 30+ years of experience managing a time-critical global cell therapy supply chain to troubleshoot issues when they arise
- Leverage established infrastructure, processes and relationships for continued product delivery
Additional Services to Support Cell and Gene Therapy Development
Collection Network Onboarding
- Facilitate and streamline apheresis center onboarding
- Assess infrastructure and ability to collect for your autologous cell therapy protocol
- Conduct quality system audit
- Develop and execute therapy-specific training
- Conduct mock shipment prior to first collection
- Provide first collection support
Collection Network Management
- Monitor compliance with autologous therapy protocol
- Provide ongoing collection support to apheresis centers
- Provide refresher training
- Conduct an audit every two years
- Assist in researching quality concerns
- Track KPIs
Quality System Audit Program
- Activates collection sites faster through licensing of quality system audit results
- Provides a comprehensive view of the center’s quality system
- Measures compliance with GTP and GMP (as GMP applies to apheresis sites and cell therapy labs)
Outcomes Data Collection and Analysis
- Leverages CIBMTR® industry-leading outcomes registry for autologous and allogeneic cell therapies
- Meets regulatory requirements for long-term tracking of commercial cell and gene therapies
- Includes training clinical sites on reporting data for outcomes tracking
Consulting
- HLA population modeling for allogeneic cell bank buildout
- Best practices in clinical trial setup
- Advice on HLA characteristics to keep in mind
- Additional unique capabilities developed by managing the cell therapy supply chain and clinical research
Unrivaled experience. Reliable solutions.
Our cell and gene therapy solutions are powered by the unparalleled expertise of the National Marrow Donor Program®/Be The Match®. Our team has learned valuable lessons over the past 30+ years of time-critical cell therapy delivery that we’re passing on to companies like yours. Discover how, together, we can empower the discovery, development and delivery of next-generation therapies for patients.
What our clients say about our service
We’re ready to put our experience to work for you
When you’re choosing a solutions provider, cell therapy experience matters. We’ve successfully delivered more than 108,000 time-sensitive products around the globe. Let’s discuss how we can save more lives through cell and gene therapy together.